EPORISE 2000 INJECTION

Eporise 2000 Injection is a recombinant erythropoietin therapy used for the treatment of anemia associated with chronic kidney disease, dialysis, and certain cancer treatments. It contains Erythropoietin Alfa, which stimulates the bone marrow to increase red blood cell production. This helps improve hemoglobin levels and supports better oxygen circulation in the body under medical supervision.

Eporise 2000 Injection is commonly prescribed to reduce the need for blood transfusions in patients with low red blood cell counts. Correcting anemia gradually and effectively helps enhance stamina, reduce weakness, and improve overall well-being. Proper dosage adjustment and regular hemoglobin monitoring are essential for safe therapy.

Eporise 2000 Injection ensures consistent efficacy and safety. It is widely supplied to hospitals, nephrology centers, and global pharmaceutical markets for reliable anemia management solutions.

Product Features

• Contains Erythropoietin Alfa 2000 IU
• Stimulates natural red blood cell production
• Used for CKD and chemotherapy-induced anemia
• Helps reduce blood transfusion dependency
• Quality-assured sterile injectable formulation

How It Helps

• Raises hemoglobin levels safely
• Improves oxygen supply to tissues
• Reduces fatigue and weakness
• Supports long-term anemia control